Equity Overview
Price & Market Data
Price: $2.01
Daily Change: -$0.03 / 1.49%
Daily Range: $0 - $0
Market Cap: $27,561,120
Daily Volume: 0
Performance Metrics
1 Week: -9.05%
1 Month: -21.18%
3 Months: -6.73%
6 Months: -66.61%
1 Year: -85.54%
YTD: -76.63%
Company Details
Employees: 46
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.